tiprankstipranks
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
Holding AXSM?
Track your performance easily

Axsome Therapeutics (AXSM) Ownership - Who Owns Axsome Therapeutics?

1,900 Followers

Axsome Therapeutics (AXSM) Ownership Overview

1.40%18.09%40.35%13.08%27.08%
40.35% Other Institutional Investors
13.08% ETFs
27.08% Public Companies and Individual Investors
The ownership structure of Axsome Therapeutics (AXSM) stock is a mix of institutional, retail, and individual investors. Approximately 71.52% of the company’s stock is owned by Institutional Investors, 1.40% is owned by Insiders, and 27.08% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$463369
Sep 30, 2024
xxxxxxxxxxxxx
$2022075
Sep 30, 2024
xxxxxxxxxxxxx
$22671145
Sep 30, 2024
xxxxxxxxxxxxx
$26832396

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,807,962Institution7.86%371,276,295
3,284,911Institution6.78%320,278,823
2,360,077Institution4.87%230,107,508
1,955,433Institution4.03%190,654,718
1,000,000Institution2.06%97,500,000
951,927Institution1.96%92,812,883
782,844Institution1.62%76,327,290
583,229Institution1.20%56,864,828
484,477Institution1.00%47,236,508
451,866Insider0.93%44,056,935

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,284,911Institution6.78%320,278,823
951,927Institution1.96%92,812,883
583,229Institution1.20%56,864,828
484,477Institution1.00%47,236,508
408,198Institution0.84%39,799,305
371,100Institution0.77%36,182,250
286,036Institution0.59%27,888,510
217,389Institution0.45%21,195,428
185,025Institution0.38%18,039,938
179,716Institution0.37%17,522,310

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,302,080Institution2.69%115,924,182
1,000,486Institution2.06%97,547,385
1,022,976Institution2.11%91,075,553
607,168Institution1.25%54,056,167
562,389Institution1.16%50,069,493
328,059Institution0.68%31,985,753
270,061Institution0.56%26,330,948
195,675Institution0.40%19,309,209
166,040Institution0.34%14,782,541
98,501Institution0.20%9,603,848

FAQ

Who Owns Axsome Therapeutics Inc (AXSM)?
According to the latest TipRanks data, approximately 40.35% of the company's stock is held by institutional investors, 1.40% is held by insiders, and 27.08% is held by retail investors.
    What percentage of Axsome Therapeutics Inc (AXSM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 40.35% of Axsome Therapeutics Inc (AXSM) stock is held by institutional investors.
      What percentage of Axsome Therapeutics Inc (AXSM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 27.08% of Axsome Therapeutics Inc (AXSM) stock is held by retail investors.
        Who owns the most shares of Axsome Therapeutics Inc (AXSM)?
        Vanguard owns the most shares of Axsome Therapeutics Inc (AXSM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis